HOXB3 and neoplasm: Together, our data indicate that HOXB3 protein is demonstrated to be alternatively transcriptive effector of WNT signaling that is responsible for tumor progression in WNT-activated CRPC and may serve as a potential therapeutic target for the subgroup of patients.